Histogen Inc. short interest in 2018
In 2018, Histogen Inc.'s disclosed short interest ran from 4.41% of shares outstanding on 12 Jan 2018 to 9.92% on 31 Dec 2018, a change of +5.51 percentage points. The year's high was 11.39% on 31 Oct 2018 and its low 3.55% on 29 Mar 2018, averaging 6.85% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.00 days on 15 Aug 2018. Full history: Histogen Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2018 in figures
- Start of year
- 4.41% (12 Jan 2018)
- End of year
- 9.92% (31 Dec 2018)
- Change
- +5.51 pp
- High
- 11.39% (31 Oct 2018)
- Low
- 3.55% (29 Mar 2018)
- Average
- 6.85%
- Highest days to cover
- 9.00 (15 Aug 2018)
- SEC filings marked
- 8
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 4.41% | 4.84 | |
| 31 Jan 2018 | 4.36% | 2.57 | |
| 15 Feb 2018 | 4.45% | 2.32 | |
| 28 Feb 2018 | 4.58% | 3.36 | |
| 15 Mar 2018 | 3.69% | 1.00 | results (8-K), 10-K filed |
| 29 Mar 2018 | 3.55% | 2.22 | |
| 13 Apr 2018 | 5.57% | 1.43 | |
| 30 Apr 2018 | 8.64% | 4.01 | |
| 15 May 2018 | 8.33% | 5.63 | results (8-K), 10-Q filed |
| 31 May 2018 | 7.89% | 6.69 | |
| 15 Jun 2018 | 7.89% | 2.32 | |
| 29 Jun 2018 | 5.36% | 1.99 | |
| 13 Jul 2018 | 5.22% | 5.46 | |
| 31 Jul 2018 | 5.80% | 6.72 | |
| 15 Aug 2018 | 5.54% | 9.00 | results (8-K), 10-Q filed |
| 31 Aug 2018 | 5.34% | 2.86 | |
| 14 Sep 2018 | 5.27% | 3.19 | |
| 28 Sep 2018 | 8.22% | 1.81 | |
| 15 Oct 2018 | 9.72% | 6.67 | |
| 31 Oct 2018 | 11.39% | 7.32 | |
| 15 Nov 2018 | 10.97% | 3.72 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 10.60% | 8.30 | |
| 14 Dec 2018 | 7.73% | 1.13 | |
| 31 Dec 2018 | 9.92% | 3.25 |
See also: Histogen Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.